COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

•A MS patient treated with ocrelizumab healed from COVID-19 without consequences•Immunosuppression might have played favorable role•This report supports the use of immunosuppressants in serious COVID-19 c Coronavirus disease 19 (COVID-19) is a novel disease entity that is spreading throughout the wo...

Full description

Saved in:

Bibliographic Details
Published in:	Multiple sclerosis and related disorders Vol. 42; p. 102120
Main Authors:	Novi, Giovanni, Mikulska, Malgorzata, Briano, Federica, Toscanini, Federica, Tazza, Francesco, Uccelli, Antonio, Inglese, Matilde
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01.07.2020
Subjects:	Antibodies, Monoclonal, Humanized - therapeutic use Betacoronavirus Case Report Coronavirus Infections - complications Coronavirus Infections - physiopathology COVID-19 Humans Immunologic Factors - therapeutic use Male Middle Aged Multiple Sclerosis, Chronic Progressive - complications Multiple Sclerosis, Chronic Progressive - drug therapy Neurology Pandemics Pneumonia, Viral - complications Pneumonia, Viral - physiopathology Protective Factors SARS-CoV-2 Severity of Illness Index
ISSN:	2211-0348, 2211-0356, 2211-0356
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!